Walder Wyss advised CorFlow Therapeutics AG on the deal. Kellerhals Carrard advised Broadview Ventures and Panakes Partners. CorFlow Therapeutics AG completed a series B financing round...
CorFlow Therapeutics AG’s €44 Million Series B Financing Round
RES’ Acquisition Of Sulzer & Schmid Laboratories AG
Bär & Karrer acted as legal advisor to RES in this transaction, Walder Wyss advised Sulzer & Schmid Laboratories AG. RES, a leading independent renewable energy...
EQT’s Acquisition Of Majority Stake In Acronis
Walder Wyss acted as Swiss legal advisor to Acronis. EQT was advised by Milbank and Bär & Karrer. Acronis and EQT announced that EQT X fund...
Bregal Unternehmerkapital’s Acquisition Of Majority Stake In BSI Software From Capvis
Walder Wyss advised Bregal Unternehmerkapital; Bär & Karrer acted for Capvis; Niederer Kraft Frey acted for BSI Software AG. Bregal Unternehmerkapital acquired a majority stake in...
Keysight Technologies Inc’s Acquisition Of AnaPico AG
Walder Wyss advised AnaPico’s shareholders on the transaction. Keysight Technologies, Inc., with its registered seat in Santa Rosa, California, USA (NYSE: KEYS), acquired all shares in...
SkyCell AG’s $116 Million Series D Financing Round
Walder Wyss advised SkyCell AG on all legal and tax aspects of this transaction. SkyCell AG closed its $116 million Series D financing round which embarked...
KLAR Partners Limited’s Acquisition Of BÜHLMANN Laboratories AG
Walder Wyss advised KLAR Partners on the transaction. KLAR Partners Limited acquired all shares in BÜHLMANN Laboratories AG. BÜHLMANN Laboratories is a Swiss company, located in...
Houzy AG’s Merger With Devis.ch SA
Walder Wyss has advised Houzy on the transaction. Houzy AG and its two anchor shareholders, Baloise Versicherung AG and UBS Switzerland AG, announced that Houzy and...
Boehringer Ingelheim’s CHF450 Million Acquisition of T3 Pharmaceuticals AG
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
SkyCell AG’s $57 Million Financing Round
Walder Wyss advised SkyCell AG on all legal and tax aspects on this transaction. Swiss based SkyCell AG has completed a USD 57 million equity financing...
Pexapark’s €20 Million Series C Funding Round
Walder Wyss acted as legal advisor to Pexapark in this transaction. Pexapark, the specialist provider of power purchase agreement (PPA) price reference, risk and portfolio management...
ITS Kanal Services AG’s Acquisition of Restclean AG
Walder Wyss advised ITS Kanal Services Ltd on the acquisition. ITS Kanal Services AG acquired Restclean AG. Restclean AG is a specialist in the field of...